Intussusception in a Premature Infant Simulating Neonatal Necrotizing Enterocolitis

Intussusception in preterm neonates: A systematic review of a rare condition

“…distension Gastric residue Bloody stools Abd. Mass Location Perforation Outcome Spencer et al [ 3 ] F 28 Not given Not given Died preop Yes No No No Ileum Yes Died Yoo et al [ 4 ] M 34 2140 2 2 Yes Yes No No Ileocolic Yes Survived Stine et al [ 5 ] F 28 970 6 33 Yes Yes Yes No Ileum No Survived Smith et al [ 6 ] F 29 910 21 43 Yes Yes Yes No Ileum No Survived Glick et al [ 7 ] M 28 1070 14 17 Yes No Yes Yes Ileum Yes Survived Carman et al [ 8 ] M 25 740 9 15 Yes Yes Yes No Ileum No Survived Blair et al [ 9 ] M 26 720 8 ...…”

Intussusception in preterm infants: case report and literature review

“…Histological studies suggest that intussusception may occur ®rst, presumably prenatally, leading to vascular impairment with subsequent bowel necrosis resulting in secondary congenital intestinal atresia [5,17]. In 4 of the 17 reviewed preterm infants [7,13,15,17], a concomitant atretic segment was found at the time of delayed surgery. Clinical signs of intussusception appeared to be nonspeci®c in the reported patients.…”

Clinical Insights into the Gastrointestinal Manifestations of COVID-19

“…The COVID-19 is currently being treated with antiviral agents that are under experimentation for effectiveness. These agents include chloroquine, chloroquine/hydroxychloroquine, remdesivir (novel nucleotide analog), lopinavir-ritonavir (protease inhibitor) and tocilizumab (IL-6 inhibitor) [55][56][57][58][59][60][61][62][63][64][65][66][67][68]. Each of these agents was shown to be effective against SARS-CoV in preliminary in vivo and in vitro studies; however, further human clinical trials are needed to assess the effectiveness of these agents [69,70].…”